Adv/ Rsv/ MP Antigen Combo Rapid Test Kit (LFIA)
Contact Supplier
Product Highlights
- Triple Pathogen Detection: Rapidly detects Adenovirus (ADV), Respiratory Syncytial Virus (RSV), and Mycoplasma pneumoniae (MP) antigens in one test.
- CE and ISO Certified: Manufactured in a GMP workshop meeting FDA, CE, and CFDA standards with full certification compliance.
- Flexible Customization: Offers full customization, minor customization, and flexible options from samples or designs.
- High Accuracy Protocol: Includes lysis buffer for sample treatment; results observed within 20-25 minutes for optimal accuracy.
- Versatile Sample Types: Compatible with anterior nasal, nasopharyngeal, and throat secretions for flexible clinical use.
- Professional R&D Team: Developed by experts from top universities with over 50% R&D personnel and advanced technology platforms.
- Fast Lead Time: Average lead time within 15 workdays for both peak and off-season orders.
Product Attributes
- Customization
- Available
- Type
- IVD Reagent
- Certification
- CE/ISO
- Model NO.
- Antigen Test
- Transport Package
- Box+Carton
- Specification
- 401mm*673mm*475mm
- Trademark
- OBM/OEM
- Origin
- China
- HS Code
- 3002150090
- Production Capacity
- 5, 000, 000 Pieces/Month
Product Images of Adv/ Rsv/ MP Antigen Combo Rapid Test Kit (LFIA)
Find Similar Products
Product Description
Intended Use
ADV/RSV/MP Antigen Combo Rapid Test Kit (LFIA) is an immunochromatography based one step in vitro test. It is designed for the rapid qualitative detect Adenovirus(ADV), Respiratory syncytial virus(RSV), Mycoplasma pneumoniae (MP) antigen in swabs from individuals suspected of ADV, RSV and MP. It can be used for detecting ADV, RSV and MP infection rapidly, which is often used as an auxiliary method in the clinical diagnosis, but not as the only basis.
Introduction
Respiratory syncytial virus (RSV) belongs to Pneumovirus of Paramyxoviridae with only one serotype, which is a single stranded negative-strand RNA virus with an envelope. RSV infection mainly causes bronchiolitis and pneumonia in infants under 6 months of age and upper respiratory tract infections such as rhinitis and colds in older children and adults.
Mycoplasma pneumoniae is a kind of cell structure without cell wall, between bacteria and viruses, the smallestprokaryotic cell type of microorganism. Mycoplasma pneumoniae is the main type of pathogen causing respiratory tract infections, which usually lead to bronchitis and atypia Pneumonia and a variety of extrapulmonary complications seriously endanger the health of children and adolescents.
Test Kit contents
Storage Instructions
The test kit should be stored away from direct sunlight at 2ºC to 30ºC with a shelf-life of 24 months. Do not freeze.
Sample Requirements
One test cassette can only be used to test one sample type. Sample types include anterior nasal secretion, nasopharyngeal secretion and throat secretion.
Jiangsu Medomics Medical Technology Co., Ltd., is located at Biotech and Pharmaceutical Valley of the National Jiangbei New Area, Nanjing, Jiangsu Province. It is an international high-tech enterprise driven by innovation in the area of medical devices R&D, production and sales. Medomics focuses on diagnosis of microorganisms, tumors and some rare diseases, mainly engaged in the research and development, production and sales of in vitro diagnostic reagents and automatic instruments.
Medomics owns two R&D centers in China and the US, independent intellectual property rights of fluorescent staining technology, protein labeling technology, time-resolved immunofluorescence detection technology, image processing and analysis technology and other innovative technology platforms, as well as a total of more than 10,000 square meters of GMP purification production workshop that meets the product standards of FDA, CE and CFDA. Until now, Medomics has more than 100 employees across the world and R&D personnel accounts for over 50%. Medomics also has a multidisciplinary expert team with abundant experience in the industry, including senior experts in immunology, microbiology, applied physics, polymer materials, medical imaging, optical systems, etc. The members of the technical team are led by doctors from many famous institutions, such as Osaka University, North Carolina University, University of Nebraska Lincoln, Zhejiang University, Sichuan University and other institutions.
About the Supplier
This supplier has been audited by BV. Verify the report on the official BV website with ID "MIC-ASR244532". Items marked "" are certified.
Company Profile
Jiangsu Medomics Medical Technology Co., Ltd., is located at Biotech and Pharmaceutical Valley of the National Jiangbei New Area, Nanjing, Jiangsu Province. It is an international high-tech enterprise driven by innovation in the area of medical devices R&D, production and sales. Medomics focuses on diagnosis of microorganisms, tumors and some rare diseases, mainly engaged in the research and development, production and sales of in vitro diagnostic reagents and automatic instruments.
Medomics owns two R&D centers in China and the US, independent intellectual property rights of fluorescent staining technology, protein labeling technology, time-resolved immunofluorescence detection technology, image processing and analysis technology and other innovative technology platforms, as well as a total of more than 10, 000 square meters of GMP purification production workshop that meets the product standards of FDA, CE and CFDA. Until now, Medomics has more than 100 employees across the world and R&D personnel accounts for over 50%. Medomics also has a multidisciplinary expert team with abundant experience in the industry, including senior experts in immunology, microbiology, applied physics, polymer materials, medical imaging, optical systems, etc. The members of the technical team are LED by doctors from many famous institutions, such as Osaka University, North Carolina University, University of Nebraska Lincoln, Zhejiang University, Sichuan University and other institutions.
Medomics developed IgM/IgG antibody detecting kit with the team of Zhong Nanshang. And Medomics published the first research paper on international journal together with State Key Laboratory of Respiratory Disease (National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health). The detecting kit was validated by CDC, Harvard Medical School and Columbia University Irving Medical Center etc. Until May 2020, the kit has been exported to dozens of countries and areas, making great help.
At present, Medomics's series product have been developed according to ISO 13485 Quality system and European CE Certification.
About Our Factory & Business Background
-
Business Type
- Manufacturer/Factory & Trading Company
- Address
- 3 / F, Building D, Phase Ii, Zhongdan Ecological Life Science Industrial Park, 3-1 Xinjinhu Road, Jiangbei New District, Nanjing, Jiangsu, China
-
Plant Area
- 12871.57 square meters
-
Number of Employees
- 156
-
Registered Capital
- 25,519,651 RMB
-
Terms of Payment
- LC, T/T, D/P, PayPal, Western Union, Small-amount payment
-
International Commercial Terms(Incoterms)
- FOB, CIF, CFR, EXW
-
Average Lead Time
-
Peak Season Lead Time: within 15 workdays
Off Season Lead Time: within 15 workdays -
Nearest Port
- Shanghai Port
-
Minimum Order Quantity
- 1 Set
-
Supply Chain Partners
- 28
Our Production Capability & Technical Expertise
-
Main Products
- In Vitro Diagnostics
-
Production Lines
- 1
-
Production Machines
- Auto Processing Line
-
QA/QC inspectors
- 4 people
-
Inspection Type for Finished Products
- Random inspection(Visual inspection & Function inspection)
-
Inspection Method for Finished Products
- Have instructions and uniformly followed
-
Customization Options
- Customization from Samples, Customization from Designs, Full Customization, Minor Customization, Flexible customization
-
ODM Service Available
- Yes
-
OEM Service Available
- Yes
-
R&D Engineers
- 42 people
-
Traceability of Raw Materials
- Yes
Our Industry Experience & Global Business Record
-
Year of Establishment
- 2017-10-12
-
Export Year
- 7 Years
-
Main Markets
- Southeast Asia/ Mideast, Africa, Australia
-
Repeat Buyers Choice
- 80%~100%
-
Number of Foreign Trading Staff
- 6
-
Overseas Agent/Branch
- No
-
New Products Launched in Last year
- Yes
Our Certifications, Standards & Industry Recognition
-
Cooperated with Fortune 500
- No
FAQ
- What pathogens does this test kit detect?
- It is designed for the rapid qualitative detection of Adenovirus (ADV), Respiratory syncytial virus (RSV), and Mycoplasma pneumoniae (MP) antigens.
- What types of samples can be used?
- Sample types include anterior nasal secretion, nasopharyngeal secretion, and throat secretion. Nasopharyngeal or throat secretions are recommended for accuracy.
- What is the reading time for the results?
- Results should be observed within 20-25 minutes. Results observed after 25 minutes are considered invalid.
- Is customization available for this product?
- Yes, customization options include customization from samples, designs, full customization, minor customization, and flexible customization.
- What is the minimum order quantity (MOQ)?
- The Minimum Order Quantity is 1 Set.
- What are the payment terms?
- Terms of payment include LC, T/T, D/P, PayPal, Western Union, and Small-amount payment.
- What is the average lead time for production?
- The average lead time is within 15 workdays for both peak season and off-season.
Send your message to this supplier
People who viewed this also viewed
Find Similar Products By Category
- Supplier Homepage
- Products
- Virus Rapid Test Kit
- Others Virus Rapid Test Kit
- Adv/ Rsv/ MP Antigen Combo Rapid Test Kit (LFIA)
Related Categories
Hot Searches
- Medical Test Factories
- Diagnostic Equipment Factories
- Test Strip Factories
- Test Kit Factories
- Virus Rapid Test
- Virus Rapid Test Kit
- Antigen Rapid Test
- Antigen Rapid Test Kit
- Rapid Test Kit
- Ivd Bulkbuy